Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Seaman, J. S.
* Articles by Schindler, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Seaman, J. S.
* Articles by Schindler, L.
Related Collections
* Atypical Neuroleptics
* Conventional Neuroleptics
* Somatoform Disorders
* Anticonvulsants
* Antidepressants
* Anxiolytics
* Lithium
* Other Somatic Therapy
Psychosomatics 46:250-253, June 2005
© 2005 The Academy of Psychosomatic Medicine

Dissolution of Common Psychiatric Medications in a Roux-en-Y Gastric Bypass Model

Jeff S. Seaman, M.S., M.D., Steven P. Bowers, M.D., Patricia Dixon, M.S., and Libby Schindler, Pharm.D.

Received Feb. 26, 2004; revision received Aug. 4, 2004; accepted Sept. 13, 2004. From the Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Okla.; and the Bariatric Surgery Clinic and Department of Clinical Pharmacy, Wilford Hall Medical Center, Lackland AFB, Tex. Address correspondence and reprint requests to Dr. Seaman, Department of Psychiatry, Oklahoma University, 10204 Green Valley Rd., Oklahoma City, OK 73151; jeff-seaman{at}ouhsc.edu (e-mail).

Large numbers of Roux-en-Y gastric bypass (RYGB) surgery patients have psychiatric illnesses that are in part treated with medication preoperatively, but there are no objective data to guide psychiatric drug dosing postoperatively. An in vitro drug dissolution model was developed to approximate the gastrointestinal environment of the preoperative (control) and post-RYGB states. Medication tablets were placed in the two environments, and the median calculated weights of the dissolved portions were compared. Ten of 22 psychiatric medication preparations had significantly less dissolution and two had significantly greater dissolution in the post-RYGB environment, compared with the control environment. The results suggest a need for an in vivo study of serum drug levels after RYGB surgery in patients taking psychiatric medications. Differences in the pharmacokinetics of the postoperative RYGB patient may necessitate adjustments in dosing.




This article has been cited by other articles:


Home page
J Am Board Fam MedHome page
S. R. Magee, G. Shih, and A. Hume
Malabsorption of Oral Antibiotics in Pregnancy after Gastric Bypass Surgery
J Am Board Fam Med, May 1, 2007; 20(3): 310 - 313.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org